Eden Research plc
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Eden Research plc develops and supplies biopesticide products and natural microencapsulation technologies using its proprietary plastic-free Sustaine platform to the global crop protection, animal health, and consumer products industries. The company offers crop protection solutions including Mevalone, a biofungicide for foliar diseases such as Botrytis, powdery mildew, and downy mildew in open-field, greenhouse, and high-value fruit and vegetable crops; Cedroz, a terpene-based nematicide targeting soil pests like root-knot nematodes in collaboration with Eastman Chemical; and Ecovelex, a seed treatment product; as well as animal health products encompassing shampoos, conditioners, skin disease controls, odour controls, flea and tick treatments, parasite treatments, and insect sprays; and consumer products such as head-lice treatments, deodorants, odour neutralisers, fragrances, wound-care solutions, and food flavourings. Eden Research plc operates primarily in Europe, the United Kingdom, Kenya, Australia, the United States, and Italy, targeting growers, farmers, horticulturists, and agricultural input distributors with low-residue, sustainable alternatives to conventional pesticides. Founded in 1995 and headquartered at 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, the AIM-quoted company (ticker: EDEN.L; OTC: EDNSF) focuses on the agrochemical segment alongside biocides, human health, and animal health. Recent developments include regulatory approval for Mevalone against powdery mildew on grapes in California in May 2025; a Knowledge Transfer Partnership grant from Innovate UK and strategic collaboration with Royal Holloway, University of London, announced in June 2025 to accelerate Ecovelex seed treatment expansion; temporary authorisation for Ecovelex-treated maize seeds in Italy in November 2025 for the 2026 growing season; ongoing partnerships with SCP Cam, Moxen, Eastman Chemical for Cedroz commercialisation and expansion, Corta for animal health products like Eelic in Europe, and others for market development in nematodes, metritis treatments, and new territories.
Company News
Eden Research seals equity raise, investors eye expedited commercialisation
Seeing Machines is monitoring systems after cyberthreat but says its found no evidence of breach
Eden Research seals equity raise, investors eye expedited commercialisation
Eden Research shares rise as Mevalone gets French grape approval
Eden Research shares rise as Mevalone gets French grape approval
Greatland confirms production growth in fourth quarter
Eden Research edges higher after Italy renews approval for Ecovelex seed treatment
Eden Research edges higher after Italy renews approval for Ecovelex seed treatment
Empire Metals rises as directors buy shares
Eden Research shares surge 20% on California approval for key fungicide
Eden Research's regulatory wins keep coming at breakneck pace
Eden Research's Mevalone fungicide added to Organic Input List in Germany
Eden Research CEO talks revenue growth and regulatory wins - ICYMI
Eden Research hails another year of 'sizeable growth'
Eden Research eyes more growth with label extensions and approvals - ICYMI
Eden Research revenue surges as regulatory momentum continues
Eden Research: Greek authorities grant temporary approval for key product
Eden Research moving rapidly in Germany after approval says CEO - ICYMI
Eden Research appoints new head of regulatory affairs